Fowke Jay H, McLerran Dale F, Gupta Prakash C, He Jiang, Shu Xiao-Ou, Ramadas Kunnambath, Tsugane Shoichiro, Inoue Manami, Tamakoshi Akiko, Koh Woon-Puay, Nishino Yoshikazu, Tsuji Ichiro, Ozasa Kotaro, Yuan Jian-Min, Tanaka Hideo, Ahn Yoon-Ok, Chen Chien-Jen, Sugawara Yumi, Yoo Keun-Young, Ahsan Habibul, Pan Wen-Harn, Pednekar Mangesh, Gu Dongfeng, Xiang Yong-Bing, Sauvaget Catherine, Sawada Norie, Wang Renwei, Kakizaki Masako, Tomata Yasutake, Ohishi Waka, Butler Lesley M, Oze Isao, Kim Dong-Hyun, You San-Lin, Park Sue K, Parvez Faruque, Chuang Shao-Yuan, Chen Yu, Lee Jung Eun, Grant Eric, Rolland Betsy, Thornquist Mark, Feng Ziding, Zheng Wei, Boffetta Paolo, Sinha Rashmi, Kang Daehee, Potter John D
Am J Epidemiol. 2015 Sep 1;182(5):381-9. doi: 10.1093/aje/kwv089. Epub 2015 Aug 4.
Many potentially modifiable risk factors for prostate cancer are also associated with prostate cancer screening, which may induce a bias in epidemiologic studies. We investigated the associations of body mass index (weight (kg)/height (m)(2)), smoking, and alcohol consumption with risk of fatal prostate cancer in Asian countries where prostate cancer screening is not widely utilized. Analysis included 18 prospective cohort studies conducted during 1963-2006 across 6 countries in southern and eastern Asia that are part of the Asia Cohort Consortium. Body mass index, smoking, and alcohol intake were determined by questionnaire at baseline, and cause of death was ascertained through death certificates. Analysis included 522,736 men aged 54 years, on average, at baseline. During 4.8 million person-years of follow-up, there were 634 prostate cancer deaths (367 prostate cancer deaths across the 11 cohorts with alcohol data). In Cox proportional hazards analyses of all cohorts in the Asia Cohort Consortium, prostate cancer mortality was not significantly associated with obesity (body mass index >25: hazard ratio (HR) = 1.08, 95% confidence interval (CI): 0.85, 1.36), ever smoking (HR = 1.00, 95% CI: 0.84, 1.21), or heavy alcohol intake (HR = 1.00, 95% CI: 0.74, 1.35). Differences in prostate cancer screening and detection probably contribute to differences in the association of obesity, smoking, or alcohol intake with prostate cancer risk and mortality between Asian and Western populations and thus require further investigation.
许多前列腺癌潜在的可改变风险因素也与前列腺癌筛查相关,这可能在流行病学研究中导致偏差。我们在前列腺癌筛查未广泛应用的亚洲国家,调查了体重指数(体重(千克)/身高(米)²)、吸烟和饮酒与致命性前列腺癌风险之间的关联。分析纳入了1963年至2006年期间在亚洲队列联盟的6个南亚和东亚国家开展的18项前瞻性队列研究。体重指数、吸烟和饮酒量在基线时通过问卷调查确定,死亡原因通过死亡证明确定。分析纳入了平均基线年龄为54岁的522,736名男性。在480万人年的随访期间,有634例前列腺癌死亡(在有饮酒数据的11个队列中有367例前列腺癌死亡)。在亚洲队列联盟所有队列的Cox比例风险分析中,前列腺癌死亡率与肥胖(体重指数>25:风险比(HR)=1.08,95%置信区间(CI):0.85,1.36)、曾经吸烟(HR =1.00,95%CI:0.84,1.21)或大量饮酒(HR =1.00,95%CI:0.74,1.35)均无显著关联。前列腺癌筛查和检测的差异可能导致亚洲和西方人群在肥胖、吸烟或饮酒量与前列腺癌风险及死亡率之间的关联存在差异,因此需要进一步研究。